EUVIMEDEUVIMED entdecken
Crossref

Anxiolytic Effect of Sesamol, Possibly Through the GABAkine Interaction Pathway

Md Tahajul Islam, Abdul Malik, Abdullah K Alshememry, Raihan Chowdhury iD, Md Shimul Bhuia iD, Sabiha Fatima, Md Samim Hossen, Asraful Islam Rakib, Faysal Mollah, Md Showkoth Akbor, Mehedi Hasan Bappi iD, Md Abu Saim und 1 weitere

Drug Development Research · 2024

DOI: 10.1002/ddr.70028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2024. Verfasst von Md Tahajul Islam und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh. Hauptthemen laut MEDLINE: Anti-Anxiety Agents, Phenols, Receptors, GABA-A, Benzodioxoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: The authors extend their appreciation to King Saud University for funding this work through research supporting project (RSPD2024R966), Riyadh, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Plant‐based components have helped generate novel lead molecules and scaffolds for anxiety research in psychopharmacology. The present study examined the anxiolytic properties of sesamol (SES), a phenolic lignan derived from Sesamum indicum , employing both in vivo and computational methods to understand its mechanisms of action. In this experiment, adult Swiss albino mice received various doses of SES (25 and 50 mg/kg, p.o.) orally. Afterward, a series of behavioral assessments, including open field, swing, hole cross, and light–dark testing, were conducted. The impact of the GABAergic agonist diazepam (DZP‐1 mg/kg, i.p.) along with the antagonist flumazenil (FLU‐0.1 mg/kg, i.p.) has been studied as provided concurrently with the SES‐50 group. Computational studies were performed to comprehend the interaction between SES and GABA A receptor subunits (α 2 and α 3 ). The results of our investigation revealed that SES dose‐dependently and significantly ( p < 0.05) reduced the number of square crosses, hole crosses, swings, grooming, and rearing along with a reduction of light residence time in animals. When combined with DZP, SES‐50 significantly reduced all these parameters, while altering with FLU‐0.1. The molecular docking analysis showed that the SES has a relatively good binding score (−5.03 ± 0.15 and −5.25 ± 0.23 kcal/mol) with GABA A receptor α 2 and α 3 subunits, respectively. The SES triggers anxiolytic effects via GABA A receptor α 2 and α 3 subunit interactions. Furthermore, precise and comprehensive preclinical research must be considered to validate potential SES targets for anxiolytic impact, clinical trial efficacy, and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Anxiety AgentsPhenolsReceptors, GABA-ABenzodioxolesMolecular Docking SimulationBehavior, AnimalAnimalsMiceMaleAnxietyDiazepamFlumazenilDose-Response Relationship, Drug

Stichwörter der Autor:innen

GABAergic interactionanxietycomputational studyin vivo studysesamol

Substanzen

Anti-Anxiety AgentssesamolPhenolsReceptors, GABA-ABenzodioxolesDiazepamFlumazenil

Autor:innen und Institutionen

  • Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh.
  • Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Bioinformatice and Drug Innovation Laboratory, BioLuster Research Center Ltd., Gopalganj, Dhaka, Bangladesh.
  • Department of Clinical Laboratory Science, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
  • School of Pharmacy, Jeonbuk National University, Jeonju, Republic of Korea.
  • Pharmacy Discipline, Khulna University, Khulna, Bangladesh.

ORCID-Profile: Raihan Chowdhury, Md Shimul Bhuia, Mehedi Hasan Bappi, Muhammad Torequl Islam

Förderung

  • The authors extend their appreciation to King Saud University for funding this work through research supporting project (RSPD2024R966), Riyadh, Saudi Arabia

Zitieren

APA

Islam, M. T., Malik, A., Alshememry, A. K., Chowdhury, R., Bhuia, M. S., Fatima, S., Hossen, M. S., Rakib, A. I., Mollah, F., Akbor, M. S., Bappi, M. H., Saim, M. A., & Islam, M. T. (2024). Anxiolytic Effect of Sesamol, Possibly Through the GABAkine Interaction Pathway. Drug Development Research. https://doi.org/10.1002/ddr.70028

Vancouver

Islam MT, Malik A, Alshememry AK, Chowdhury R, Bhuia MS, Fatima S, et al. Anxiolytic Effect of Sesamol, Possibly Through the GABAkine Interaction Pathway. Drug Development Research. 2024. doi:10.1002/ddr.70028

BibTeX
@article{Islam2024,
  author = {Islam, Md Tahajul and Malik, Abdul and Alshememry, Abdullah K and Chowdhury, Raihan and Bhuia, Md Shimul and Fatima, Sabiha and Hossen, Md Samim and Rakib, Asraful Islam and Mollah, Faysal and Akbor, Md Showkoth and Bappi, Mehedi Hasan and Saim, Md Abu and Islam, Muhammad Torequl},
  title = {Anxiolytic Effect of Sesamol, Possibly Through the GABAkine Interaction Pathway},
  journal = {Drug Development Research},
  year = {2024},
  doi = {10.1002/ddr.70028}
}
Kostenlos starten →